Kelly Anderson

Executive Director of Health and Drug Policy

Kelly Anderson serves as executive director of health and drug policy at the U.S. Chamber’s Global Innovation Policy Center (GIPC). Anderson is primarily responsible for leading the Chamber’s Discover & Deliver campaign, which tells the story of the innovative biopharmaceutical industry’s capacity to respond to evolving health threats, such as COVID-19.

Anderson is also the lead of the production and marketing of the U.S. Chamber’s International IP Index. Anderson discusses the report’s findings with U.S. and foreign government officials, industry stakeholders, and international third party groups. In her nine years at the Chamber, Anderson has presented the U.S. Chamber’s IP Index at events in over a dozen global markets.

Prior to joining the Chamber, Anderson handled congressional affairs at the Embassy of Gabon in Washington, D.C. During her time at the Embassy, she worked with congressional staff to raise the profile of Gabon both on the Hill and throughout Washington, D.C. Prior to this, Anderson worked at the lobbying firm American Continental Group after previously interning on the Hill.

Anderson received an Executive Masters of Public Administration at the London School of Economics and Political Science. She earned her B.A. in Political Science from Drew University in Madison, NJ.


Global Innovation Policy Center (GIPC) @globalIPcenter 11h

By any objective metric, the Bayh-Dole Act of 1980 has been an unqualified success in growing the U.S. economy and making lives better around the world. Read more:

Reply Retweet Favorite

Subscribe for updates from GIPC